Together,
We Explore What’s
Coming Next and Why It Matters
The MedTech Value Map.
WHAT
The MedTech Value Map is a strategic framework I created to help medical technology companies navigate the path to achieving access across different health systems, proving value to payer, clinicians and health systems, and expanding globally while adapting to shifting regulatory, reimbursement, and market dynamics.
It brings clarity to a fast‑changing industry by shifting conversations away from outdated models and toward future‑looking strategy.
I designed it to fill a gap in dedicated, future-focused discussion about value, access, and strategy in MedTech. The goal is to ensure that every patient can have access to life-saving technologies through effective market access strategies and integrated operating models.
Also on substack - themedtechvaluemap.substack.com.
WHY
Medtech companies today operate in a landscape defined by shifting payer expectations, evolving regulatory requirements, and accelerating M&A activity that is rewriting strategic priorities across the industry. In this environment, success requires more than proving value,it requires engineering markets, shaping demand, and establishing category leadership.
The MedTech Value Map matters because it provides a strategic view of how medical technologies achieve access and value globally, with an eye toward the evolving dynamics of the future.
It helps the life sciences industry understand not just how value is proven, but how markets are shaped, how demand is engineered, and how category leadership is built. It is a space fully dedicated to exploring how we unlock value in a rapidly shifting global landscape.
HOW
The MedTech Value Map works by giving organizations a structured, future‑focused operating model for shaping markets, accelerating adoption, and enabling access to life‑saving technologies. It begins by defining the clinical, economic, and operational value a technology creates, then maps the evidence required to validate that value across all stakeholders.
It integrates global market access strategy, helping companies understand how different health systems evaluate value, how to anticipate regional patterns early, and how to position technologies for worldwide adoption.
For MedTech start‑ups, the MedTech Value Map acts as a clarity engine: guiding founders on what evidence matters, how to build early traction, and how to earn investor confidence.
For large companies, it strengthens medtech business development by aligning evidence, value, commercial, and regional execution—supporting portfolio decisions, informing global expansion, and shaping markets to create category leadership. Ultimately, the MedTech Value Map helps organizations engineer favorable market conditions, build demand, and create meaningful value for every stakeholder involved.
My name is Joan Hinrichs,
I imagine a world where every patient can access life‑saving technology.
What it means to create value for all stakeholders with the patient at the center.
The MedTech Value Map is my gift to you.
Subscribe for additional deeper dives. Connect with me for a custom proposal and partnership.
Comprehensive Business Strategy
Product Commercialization Strategy
I partner with teams to define where to play and how to win. Through disciplined commercialization planning, I translate clinical value into compelling market positions, craft launch strategies that accelerate adoption, and build operating models that sustain market leadership.
This service equips organizations to shape markets, influence decision‑makers, and execute with confidence.
Global Market Access Strategy
I help MedTech companies navigate global pathways and secure access in diverse health systems. My work includes assessing international reimbursement landscapes, shaping value narratives that resonate with regional stakeholders, and building access frameworks that anticipate policy shifts.
This service ensures your technology reaches patients worldwide with clarity, speed, and strategic precision
Evidence Generation Strategy
I design evidence generation strategies that strengthen confidence in your technology’s value. From clinical and economic study planning to real‑world evidence roadmaps, I ensure evidence aligns with market needs, access requirements, and long‑term growth goals.
This service transforms evidence into a strategic asset. Fueling adoption, informing policy, guiding resource allocation toward what creates the greatest value, and strengthening global commercialization
Shape Global Markets, Accelerate Adoption.
The MedTech Value Map helps organizations engineer favorable market conditions, build demand, and position technologies for worldwide success.
Request a Proposal
Request a proposal from Joan Hinrichs by submiting your project objectives and timelines to initiate a consultation that identifies optimal strategies and resource allocations.